Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 7 results.
User Information
Export Records
  1. 1.   Lack of Effect from a Previous Single Dose of Nevirapine on Virologic and Immunologic Responses After 6 Months of Antiretroviral Regimens Containing Either Efavirenz or Lopinavir-Ritonavir
  2. Dlamini, J. N.; Hu, Z. H.; Somaroo, H.; Highbarger, H. C.; Follmann, D. A.; Dewar, R. L.; Pau, A. K.
  3. Pharmacotherapy. 2011, Feb; 31(2): 158-163.
  1. 2.   Detection of nonnucleoside reverse-transcriptase inhibitor-resistant HIV-1 after discontinuation of virologically suppressive antiretroviral therapy
  2. Hare, C. B.; Mellors, J.; Krambrink, A.; Su, Z. H.; Skiest, D.; Margolis, D. M.; Patel, S. S.; Barnas, D.; Frenkel, L.; Coombs, R. W.; Aweeka, F.; Morse, G. D.; Haas, D. W.; Boltz, V.; Palmer, S.; Coffin, J.; Havlir, D. V.
  3. Clinical Infectious Diseases. 2008 47(3): 421-424.
  1. 3.   Efavirenz Induces CYP2B6-Mediated Hydroxylation of Bupropion in Healthy Subjects
  2. Robertson, S. M.; Maldarelli, F.; Natarajan, V.; Formentini, E.; Alfaro, R. M.; Penzak, S. R.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2008 49(5): 513-519.
  1. 4.   Cytochrome P4502B6 (CYP2B6) G516T influences nevirapine plasma concentrations in HIV-infected patients in Uganda
  2. Penzak, S. R.; Kabuye, G.; Mugyenyi, P.; Mbamanya, F.; Natarajan, V.; Alfaro, R. M.; Kityo, C.; Formentini, E.; Masur, H.
  3. HIV Medicine. 2007, Mar; 8(2): 86-91.
  1. 5.   Crystallography and the design of anti-AIDS drugs: Conformational flexibility and positional adaptability are important in the design of non-nucleoside HIV-1 reverse transcriptase inhibitors
  2. Das, K.; Lewi, P. J.; Hughes, S. H.; Arnold, E.
  3. Progress in Biophysics and Molecular Biology. 2005, JUN; 88(2): 209-231.
  1. 6.   In search of a novel anti-HIV drug: Multidisciplinary coordination in the discovery of 4-[[4-[[4-[(1E)-2-cyanoethenyl]-2,6dimethylphenyl] amino]-2-pyrimidinyl]amino]-benzonitrile (R278474, rilpivirine)
  2. Janssen, P. A. J.; Lewi, P. J.; Arnold, E.; Daeyaert, F.; de Jonge, M.; Heeres, J.; Koymans, L.; Vinkers, M.; Guillemont, J.; Pasquier, E.; Kukla, M.; Ludovici, D.; Andries, K.; de Bethune, M. P.; Pauwels, R.; Das, K.; Clark, A. D.; Frenkel, Y. V.; Hughes, S. H.; Medaer, B.; De Knaep, F.; Bohets, H.; De Clerck, F.; Lampo, A.; Williams, P.; Stoffels, P.
  3. Journal of Medicinal Chemistry. 2005, MAR 24; 48(6): 1901-1909.
  1. 7.   Roles of conformational and positional adaptability in structure-based design of TMC125-R165335 (etravirine) and related non-nucleoside reverse transcriptase inhibitors that are highly potent and effective against wild-type and drug-resistant HIV-1 variants
  2. Das, K.; Clark, A. D.; Lewi, P. J.; Heeres, J.; de Jonge, M. R.; Koymans, L. M. H.; Vinkers, H. M.; Daeyaert, F.; Ludovici, D. W.; Kukla, M. J.; De Corte, B.; Kavash, R. W.; Ho, C. Y.; Ye, H.; Lichtenstein, M. A.; Andries, K.; Pauwels, R.; de Bethune, M. P.; Boyer, P. L.; Clark, P.; Hughes, S. H.; Janssen, P. A. J.; Arnold, E.
  3. Journal of Medicinal Chemistry. 2004 47(10): 2550-2560.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel